Alamar Biosciences

Public

Fremont, CaliforniaBiotechhttps://alamarbio.com/

Last Round

IPO Announced

Apr 17, 2026

Est. Valuation

$1.14B

Total Funding Raised

$546.12M

Company Overview

Alamar Biosciences is a biotechnology company that develops a precision proteomics platform for protein analysis and cancer detection, utilizing advanced antibody technologies to enhance disease diagnosis and facilitate early biomarker discovery for improved patient outcomes.

Sector

Biotech

Verticals

Life Sciences, LOHAS & Wellness, Oncology

AI Layer

Application

Keywords

proteomicsbiomarker detectionNULISAprecision medicineAlzheimer's researchblood-based diagnosticsliquid biopsymultiplex proteomicsclinical researchproteomics platformbiotech equipmentearly disease detectionneurology researchARGO HT systemCRO

Alamar Biosciences Comps

Public and private peers based on sector, stage, and business model.

Alamar Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alamar Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Apr 17, 2026
Convertible Debt	Jan 11, 2026
Convertible Debt	Jan 8, 2026
Grant	Jan 8, 2025
Series C	Feb 26, 2024
Series B	Sep 8, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Steve Chen

Founder, COO

Founding Team

Tod White

Chief Financial Officer & Chief Business Officer

Executive Team

Alamar Biosciences Investors

Notable investors and investment history

Alamar Biosciences investors
Investor	Rounds
U.S. Department of Health and Human Services	Grant
Braidwell	Convertible Debt
Gates Ventures	Grant
Morningside Ventures	Series B
ARCH Venture Partners	Series C
T. Rowe Price	Convertible Debt
TMCP	Series C

View all Investors

Alamar Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Alamar Biosciences Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersFremont, California

Employee Range228

Year Founded2018

Last FundingApr 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.